Pfizer’s second quarter results were well received by the market, as the company outperformed Wall Street’s expectations for ...

Global pharmaceutical company Pfizer (NYSE:PFE) reported Q2 CY2025 results beating Wall Street’s revenue expectations, with ...

Pfizer (NYSE: PFE) is a case in point, with its forward dividend yield of 7%. Although the stock is a favorite for many ...

A company that has Donald Trump Jr. on its board touted in a press release a new “initiative” to help pharmaceutical ...